Prolific Machines
Light-controlled cell line development and bioprocessing for biotechs, pharma companies and CDMOs
Highlights
- New on EvolcAdded 2026-11-14
Recent signals
What changed at Prolific Machines in the last 6 months, newest first. Each line links to its public source.
- 21 Oct 2026 In the news · Prolific Machines announced partnerships with NantWorks and Zylidac Bio CDMO prolific-machines.com
About Prolific Machines
Prolific Machines develops optogenetics-based cell line development and bioprocessing solutions that use light to control protein expression in cell cultures. Its platform combines optogenetic cell lines, illumination hardware that fits existing bioreactors, and data-driven process optimization.
The company works with biotechs, pharmaceutical companies and CDMOs. It offers preclinical cell line and process development services, platform licensing for in-house manufacturing capability, and CDMO partnerships for GMP supply.
Prolific was founded in 2020 and has open roles in Emeryville, California, mainly in analytical chemistry, cell line development, synthetic biology and hardware engineering. In October 2026 it announced new investments and partnerships with NantWorks and Zylidac Bio CDMO.
Product: Optogenetic cell line development services, light-controllable bioprocess platform with illumination add-on hardware, and platform licensing.
Jobs at Prolific Machines
More biotech & pharma companies
Protara Therapeutics
Clinical-stage biopharma developing TARA-002 cell therapy and IV choline chloride for cancer and rare disease patientsNew on EvolcPtcbio
Biopharmaceutical company developing and commercializing medicines for children and adults with serious rare diseasesNew on EvolcRemote-friendlyPulmovant
Developing inhaled therapies for patients with pulmonary diseases, starting with pulmonary hypertension associatedNew on EvolcRatiotx
Develops targeted radiopharmaceuticals for treating cancer, from discovery through early clinical trialsNew on EvolcReCode Therapeutics
Develops mRNA and gene-correction medicines for people with genetically defined diseases, including cystic fibrosisNew on EvolcRecursion
AI-enabled drug discovery and development for pharmaceutical partners and patients with oncology and rare diseasesRemote-friendlySalary transparent
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- SanityMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
- Page markupsoftware structure signature
- Page markupsoftware structure signature
Frontend frameworks
- Next.jsHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- ReactMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Related technologyimplied by Next.js
Hosting
- nginxHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Recruiting
- LeverMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
- Page markupsoftware structure signature
- Page markupsoftware structure signature
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.